To study the effects of a new group of psychotropic medications, the selective serotonin reuptake inhibitors (SSRIs), on some symptoms of young children (under 7 years old) with pervasive developmental disorders (PDD).
Method:
Open clinical trial.
Results:
Medications produced positive results in half the children, particularly those with obsessional, repetitive, and anxiety symptoms. The medication was discontinued in half the children: one-quarter for worsening of symptoms and the other quarter for doubtful side effects.
Conclusions:
SSRIs may have a role to play in ameliorating some symptoms of PDD. Further studies with standardized measurements, however, are needed to elucidate which children and what symptoms could benefit from which medication.
CampbellMPerryRSmallAMGreenWH. Overview of drug treatment in autism. In: SchoplerEMesibovGB, editors. Neurobiological issues in autism. New York: Plenum Press; 1987. p 341–56.
2.
GaulteriCTRandylEWPattersonDR. The medical treatment of autistic people. In: SchoplerEMesibovGB, editors. Neurological issues in autism. New York: Plenum Press; 1987. p 373–88.
3.
SlomanL.Use of medication in pervasive developmental disorder. In: KonstantareasMMBeitchmanJ, editors. The psychiatric clinics of North America: Pervasive developmental disorders. Philadelphia: WB Saunders Company; 1991. p 165–82.
4.
CampbellMScholperECuevaJHallinA.Treatment of autistic disorder. J Am Acad Child Adolesc Psychiatry1996;35:134–43.
5.
CampbellMHarrisJ.Resolved: Autistic children should have a trial of naltrexone. J Am Acad Child Adolesc Psychiatry1996;35:246–50.
6.
GordonCStateRCNelsonJEHamburgerSDRapoportJL. A double-blind comparison of clomipramine, desipramine and placebo in the treatment of autistic disorder. Arch Gen Psychiatry1993;50:441–7.
7.
BirmakerBWatermanGSRyanM.Fluoxetine for children and anxiety disorder. J Am Acad Child Adolesc Psychiatry1994;33:993–9.
8.
JoshiPTWalkupJTCapozzoliJADetrinesRBCoyleJT. The use of fluoxetine in the treatment of major depressive disorders in children and adolescents. In: Proceedings of the 36th Annual Meeting of the American Academy of Child and Adolescent Psychiatry; 1989 Oct 11–15; New York, NY.
9.
GellerDABiedermanJReedESpencerTWilensTE. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry1995;34:36–44.
10.
McDougleCJPriceLHGoodmanWK. Fluoxetine treatment of coincident AD and obsessive-compulsive disorder: A case report. J Autism Dev Disord1990;20:537–43.
11.
MehlingerRScheftnerWAPoznonskiE.Fluoxetine and autism. J Am Acad Child Adolesc Psychiatry1990;29:985.
12.
ToddR.Fluoxetine in autism. Am J Psychiatry1991;148:1029.
13.
CookEHRowlettRJaselskiCLeventhalBL. Fluoxetine treatment of children and adults with autistic disorder & mental retardation. J Am Acad Child Adolesc Psychiatry1992;31:739–45.
14.
BrownWAHarrisonW.Are patients who are intolerant to one serotonin reuptake inhibitor intolerant to another?J Clin Psychiatry1995;56:30–4.
